This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer or Radiation Toxicity
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

RATIONALE: Drugs, such as lovastatin, may protect normal cells from the side effects of radiation therapy. PURPOSE: This phase II trial is studying how well lovastatin works in reducing side effects after radiation therapy in women with breast cancer.

Provided treatments

  • Drug: lovastatin
  • Other: questionnaire administration
  • Procedure: adjuvant therapy
  • Radiation: accelerated partial breast irradiation
  • Radiation: external beam radiation therapy
Tris trial is registered with FDA with number: NCT00902668. The sponsor of the trial is Virginia Commonwealth University and it is looking for 3 volunteers for the current phase.
Official trial title:
A Phase II Study Using Lovastatin to Improve Cosmetic Outcome After Radiation Therapy for Breast Cancer